Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company based in Carlsbad, California, founded in 2011. The company specializes in developing therapeutics aimed at diseases related to compromised gastrointestinal barrier integrity. Its primary focus is on addressing unmet medical needs through scientifically grounded treatments. Palisade Bio's portfolio includes PALI-2108, which is being developed for the treatment of inflammatory bowel disease, encompassing conditions such as ulcerative colitis and Crohn's disease. Additionally, the company is researching PALI-1908 as part of its commitment to advancing innovative therapies in this area.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.